Related by context. Frequent words. (Click for all words.) 68 Response Evaluation Criteria 68 RECIST criteria 66 Solid Tumors 63 plus dexamethasone 62 chlorambucil 62 RECIST 62 Natalizumab 62 XELOX 62 mycophenolate mofetil 62 surrogate endpoint 62 Secondary endpoints included 61 patients evaluable 61 DOXIL 61 Lenalidomide 61 Secondary endpoints include 61 PROMACTA 61 FOLFIRI 61 mg kg dose 60 Traficet EN 60 Immunogenicity 60 alteplase 60 evaluable 60 decitabine 60 mRCC 60 cytogenetic response 60 Anti TNF 60 Ischemic 60 evaluable patients 60 neoadjuvant chemotherapy 60 eplerenone 60 Thrombolysis 59 irbesartan 59 HBsAg 59 biochemical recurrence 59 PRECiSE 59 KRAS mutations 59 adalimumab 59 Pegasys ® 59 Fludara 59 sipuleucel T 59 Taxotere ® 59 Bioavailability 59 nonresponders 59 immunohistochemical 59 Arch Neurol 59 prospectively defined 59 nab paclitaxel 59 Pharmacokinetic 59 GSK# [001] 59 ACZ# 59 Monotherapy 59 relapsing multiple sclerosis 58 azacitidine 58 complete cytogenetic 58 peginterferon 58 Myocardial 58 neoadjuvant 58 Gemzar ® 58 Natural Catastrophe Stress 58 dasatinib 58 univariate 58 Pioglitazone 58 PANSS 58 elotuzumab 58 Secondary endpoints 58 sensitivity specificity 58 neoadjuvant therapy 58 #mg dose [003] 58 annualized relapse 58 Irinotecan 58 liposomal formulation 58 peripheral blood mononuclear 58 Welchol 57 Bevacizumab 57 HER2 positive metastatic breast 57 olmesartan 57 fulvestrant 57 tolvaptan 57 multivariate analyzes 57 Postoperative 57 PsA 57 Targeted Therapy 57 bleomycin 57 TAXUS Stent 57 nilotinib 57 chemoradiotherapy 57 univariate analysis 57 gefitinib 57 ximelagatran 57 PREZISTA r 57 plus prednisone 57 pharmacodynamic effects 57 nelfinavir 57 ACR# response 57 metastatic renal cell carcinoma 57 SABCS 57 platelet reactivity 57 NOXAFIL 57 KRN# 57 Heart Failure Patients 57 PegIntron